116 related articles for article (PubMed ID: 11849626)
1. Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer.
Stathopoulou A; Angelopoulou K; Perraki M; Georgoulias V; Malamos N; Lianidou E
Clin Biochem; 2001 Nov; 34(8):651-9. PubMed ID: 11849626
[TBL] [Abstract][Full Text] [Related]
2. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
4. A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer.
Stathopoulou A; Ntoulia M; Perraki M; Apostolaki S; Mavroudis D; Malamos N; Georgoulias V; Lianidou ES
Int J Cancer; 2006 Oct; 119(7):1654-9. PubMed ID: 16708381
[TBL] [Abstract][Full Text] [Related]
5. Determination of prostate specific antigen mRNA in peripheral blood by reverse transcriptase polymerase chain reaction and a simple chemiluminometric hybridization assay in a high-throughput format.
Emmanouilidou E; Ioannou PC; Christopoulos TK; Polizois K
Anal Biochem; 2003 Feb; 313(1):97-105. PubMed ID: 12576064
[TBL] [Abstract][Full Text] [Related]
6. Development of a quantitative luminometric hybridization assay for the determination of telomerase activity.
Kolioliou M; Talieri M; Lianidou ES
Clin Biochem; 2001 Jun; 34(4):277-84. PubMed ID: 11440727
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
[TBL] [Abstract][Full Text] [Related]
8. High-throughput chemiluminometric determination of prostate-specific membrane antigen mRNA in peripheral blood by RT-PCR using a synthetic RNA internal standard.
Emmanouilidou E; Ioannou PC; Christopoulos TK
Anal Bioanal Chem; 2004 Sep; 380(1):90-7. PubMed ID: 15278342
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Ann Oncol; 2003 Jun; 14(6):849-55. PubMed ID: 12796021
[TBL] [Abstract][Full Text] [Related]
10. Competitive cytokeratin 19 RT-PCR for quantification of breast cancer cells in blood cell suspensions.
Trummer A; Kadar J; Arseniev L; Petersen D; Ganser A; Lichtinghagen R
J Hematother Stem Cell Res; 2000 Apr; 9(2):275-84. PubMed ID: 10813542
[TBL] [Abstract][Full Text] [Related]
11. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
[TBL] [Abstract][Full Text] [Related]
12. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Wei YH
Int J Cancer; 2002 Feb; 97(4):548-53. PubMed ID: 11802221
[TBL] [Abstract][Full Text] [Related]
14. Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19.
Grünewald K; Haun M; Urbanek M; Fiegl M; Müller-Holzner E; Gunsilius E; Dünser M; Marth C; Gastl G
Lab Invest; 2000 Jul; 80(7):1071-7. PubMed ID: 10908152
[TBL] [Abstract][Full Text] [Related]
15. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.
Dingemans AM; Brakenhoff RH; Postmus PE; Giaccone G
Lab Invest; 1997 Sep; 77(3):213-20. PubMed ID: 9314945
[TBL] [Abstract][Full Text] [Related]
16. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
17. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination.
Krismann M; Todt B; Schröder J; Gareis D; Müller KM; Seeber S; Schütte J
J Clin Oncol; 1995 Nov; 13(11):2769-75. PubMed ID: 7595737
[TBL] [Abstract][Full Text] [Related]
18. The detection of circulating breast cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
Bae JW; Choi KH; Kim HG; Park SH
J Korean Med Sci; 2000 Apr; 15(2):194-8. PubMed ID: 10803697
[TBL] [Abstract][Full Text] [Related]
19. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
20. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients.
Krüger W; Krzizanowski C; Holweg M; Stockschläder M; Kröger N; Jung R; Mross K; Jonat W; Zander AR
J Cancer Res Clin Oncol; 1996; 122(11):679-86. PubMed ID: 8898979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
